BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29925915)

  • 21. Participation in Competing Strategies for Colorectal Cancer Screening: A Randomized Health Services Study (PICCOLINO Study).
    Pilonis ND; Bugajski M; Wieszczy P; Rupinski M; Pisera M; Pawlak E; Regula J; Kaminski MF
    Gastroenterology; 2021 Mar; 160(4):1097-1105. PubMed ID: 33307024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial.
    Gupta S; Halm EA; Rockey DC; Hammons M; Koch M; Carter E; Valdez L; Tong L; Ahn C; Kashner M; Argenbright K; Tiro J; Geng Z; Pruitt S; Skinner CS
    JAMA Intern Med; 2013 Oct; 173(18):1725-32. PubMed ID: 23921906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rethinking the Re-Prep: Attitudes Toward Noninvasive Colorectal Cancer Screening Tests After Inadequate Bowel Preparation.
    Platt KD; Kurlander JE; Zikmund-Fisher BJ; Lipson R; Knaus M; Waljee AK; Saini SD
    Am J Gastroenterol; 2019 Oct; 114(10):1685-1687. PubMed ID: 31464741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient-Reported Needs Following a Referral for Colorectal Cancer Screening.
    Dyer KE; Shires DA; Flocke SA; Hawley ST; Jones RM; Resnicow K; Shin Y; Lafata JE
    Am J Prev Med; 2019 Feb; 56(2):271-280. PubMed ID: 30554975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
    van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
    Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness and cost of multilayered colorectal cancer screening promotion interventions at federally qualified health centers in Washington State.
    Kemper KE; Glaze BL; Eastman CL; Waldron RC; Hoover S; Flagg T; Tangka FKL; Subramanian S
    Cancer; 2018 Nov; 124(21):4121-4129. PubMed ID: 30359468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness and Cost of an Enhanced Mailed Fecal Test Outreach Colorectal Cancer Screening Program: Findings from the PROMPT Stepped-Wedge Trial.
    Coronado GD; Nyongesa DB; Escaron AL; Petrik AF; Thompson JH; Smith D; Davis MM; Schneider JL; Rivelli JS; Laguna T; Leo MC
    Cancer Epidemiol Biomarkers Prev; 2023 Nov; 32(11):1608-1616. PubMed ID: 37566431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outreach and Inreach Strategies for Colorectal Cancer Screening Among Latinos at a Federally Qualified Health Center: A Randomized Controlled Trial, 2015-2018.
    Castañeda SF; Bharti B; Rojas M; Mercado S; Bearse AM; Camacho J; Lopez MS; Muñoz F; O'Connell S; Liu L; Talavera GA; Gupta S
    Am J Public Health; 2020 Apr; 110(4):587-594. PubMed ID: 32078353
    [No Abstract]   [Full Text] [Related]  

  • 29. Mailed Letter Versus Phone Call to Increase Uptake of Cancer Screening: A Pragmatic, Randomized Trial.
    Kiran T; Davie S; Moineddin R; Lofters A
    J Am Board Fam Med; 2018; 31(6):857-868. PubMed ID: 30413542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mailed Outreach Is Superior to Usual Care Alone for Colorectal Cancer Screening in the USA: A Systematic Review and Meta-analysis.
    Jager M; Demb J; Asghar A; Selby K; Mello EM; Heskett KM; Lieberman AJ; Geng Z; Bharti B; Singh S; Gupta S
    Dig Dis Sci; 2019 Sep; 64(9):2489-2496. PubMed ID: 30915656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategies to Improve Follow-up After Positive Fecal Immunochemical Tests in a Community-Based Setting: A Mixed-Methods Study.
    Selby K; Jensen CD; Zhao WK; Lee JK; Slam A; Schottinger JE; Bacchetti P; Levin TR; Corley DA
    Clin Transl Gastroenterol; 2019 Feb; 10(2):e00010. PubMed ID: 30829917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive ability and personality as predictors of participation in a national colorectal cancer screening programme: the English Longitudinal Study of Ageing.
    Gale CR; Deary IJ; Wardle J; Zaninotto P; Batty GD
    J Epidemiol Community Health; 2015 Jun; 69(6):530-5. PubMed ID: 25648994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of a Doctor's Invitation on Participation in Colorectal Cancer Screening: A Cluster Randomized Trial.
    Barthe J; Perrodeau E; Gilberg S; Ravaud P; Ghasarossian C; Marchand-Buttin F; Deyra J; Falcoff H
    Am J Med; 2015 Sep; 128(9):1024.e1-7. PubMed ID: 25908395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach.
    Halm EA; Beaber EF; McLerran D; Chubak J; Corley DA; Rutter CM; Doubeni CA; Haas JS; Balasubramanian BA
    J Gen Intern Med; 2016 Oct; 31(10):1190-7. PubMed ID: 27279097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors associated with initial participation in a population-based screening for colorectal cancer in Catalonia, Spain: a mixed-methods study.
    García M; Borràs JM; Milà N; Espinàs JA; Binefa G; Fernández E; Farré A; Pla M; Cardona A; Moreno V
    Prev Med; 2011; 52(3-4):265-7. PubMed ID: 21295061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colorectal Cancer Screening Participation Among Asian Americans Overall and Subgroups in an Integrated Health Care Setting with Organized Screening.
    Ghai NR; Jensen CD; Corley DA; Doubeni CA; Schottinger JE; Zauber AG; Lee AT; Contreras R; Levin TR; Lee JK; Quinn VP
    Clin Transl Gastroenterol; 2018 Sep; 9(9):186. PubMed ID: 30242160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
    Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
    Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does patient education and recommendation result in increased uptake of colorectal cancer screening using the fecal occult blood test?
    Chua AH; Koh GC
    Ann Acad Med Singap; 2014 Oct; 43(10):517-8. PubMed ID: 25434624
    [No Abstract]   [Full Text] [Related]  

  • 39. Are smokers less likely to seek preventive healthcare measures in Italy?
    Carreras G; Iannucci L; Costa G; Chellini E; Gorini G
    Eur J Cancer Prev; 2018 Sep; 27(5):507-513. PubMed ID: 28379886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uptake of a colorectal cancer screening blood test in people with elevated risk for cancer who cannot or will not complete a faecal occult blood test.
    Symonds EL; Cock C; Meng R; Cole SR; Fraser RJL; Young GP
    Eur J Cancer Prev; 2018 Sep; 27(5):425-432. PubMed ID: 28368949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.